Phase II trial of carboplatin and vinblastine in adenocarcinoma of the stomach. Academic Article uri icon

Overview

abstract

  • Twenty-five previously untreated patients with advanced adenocarcinoma of the upper gastrointestinal tract were treated with a combination of carboplatin and vinblastine. Two partial responses (duration three months and six months) were seen among 22 evaluable patients. Myelosuppression was the most common toxicity and was generally mild. The 8% response rate, (95% confidence interval 2 to 24%) observed in this study indicated that carboplatin-vinblastine has only modest activity in adenocarcinoma of the upper gastrointestinal tract. Although less toxic, this regimen appears to be less effective than previously reported cisplatin-containing regimens in adenocarcinoma of the upper GI tract.

publication date

  • August 1, 1990

Research

keywords

  • Adenocarcinoma
  • Antineoplastic Combined Chemotherapy Protocols
  • Stomach Neoplasms

Identity

Scopus Document Identifier

  • 0025180319

PubMed ID

  • 2272772

Additional Document Info

volume

  • 8

issue

  • 3